Dr. Chiara Gai received her Master’s Degree in Medical Biotechnology and PhD in Medical Physiopathology at the University of Turin in 2014 and 2017, respectively. She worked as a post-doctoral fellow at the University of Turin in the Renal Immunopathology Laboratory and Physiopathology of Atherosclerosis Laboratory. She co-founded EvoBiotech in 2019 and served as chairperson until 2021. Her scientific activity has carried on in the fields of inflammation and angiogenesis, diabetes, regenerative medicine, and cell and stem cell biology. She is an expert on molecular characterization (protein, mRNA, and miRNA content) and the study of the biologic activities (angiogenesis, migration, and anti-oxidant activity) of extracellular vesicles derived from stem cells, biologic fluids (serum, plasma, and saliva), and plants. She is dedicated to the development of a large-scale production method of plant-derived extracellular vesicles.

Dr. Margherita Alba Carlotta Pomatto received her Master’s Degree in Medical Biotechnology and PhD in Medical Physiopathology at the University of Turin in 2015 and 2018, respectively. She worked as a Post-doctoral fellow at the University of Turin in the Stem Cell Laboratory, Physiopathology of Atherosclerosis Laboratory, and Renal Immunopathology Laboratory. She co-founded EvoBiotech in 2019 and served as CEO until 2021. Her scientific activity has carried on in the fields of cell and stem cell biology, oncology, regenerative medicine, inflammation, and angiogenesis. She is an expert on extracellular vesicles as therapeutic agents, delivery systems, and diagnostic tools. She has extensive experience in the molecular characterization (protein and nucleic acid content) and the study of the biologic activities (e.g., angiogenesis, proliferation, migration, anti-oxidant activity) of extracellular vesicles derived from stem cells, biologic fluids (e.g., serum, plasma, saliva), and plants. She is a specialist in several techniques for loading extracellular vesicles with nucleic acids and other drugs.

Dr. Maria Chiara Deregibus received her master’s degree in Medicine and Surgery at the University of Turin and specialized in Hygiene at the same University. She worked for several years at the University of Turin, Department of Medical Science (Incubatore 2i3T, Centro di Medicina Sperimentale—CeRMS). She has collaborated with several pharmaceutical companies such as Fresenius Medical Care and SiS-Ter S.p.A. She has 75 publications with 17,134 citations and an h-index of 52 (Google Scholar, 10 January 2024). She is an expert on extracellular vesicles derived from stem cells or biologic fluids (serum, plasma, saliva) and their biochemical characterization (protein, mRNA, miRNA content), isolation methods, biologic activities (paracrine signaling of progenitor stem cells), and possible therapeutic and diagnostic applications. She was among the first scientists to describe the ability of extracellular vesicles to transport functional nucleic acids to target cells.

Dr. Marco Dieci received his Master’s degree in Chemistry from the University of Parma in 1995. He brings over 25 years of management experience in the life science industry, specifically in clinical operations management, pharma business development, and market access. He served as CEO at Holostem, Executive Director at the facility of Children Hospital Bambino Gesù in Rome, CEO of Xellbiogene, and Operations Director at MolMed.

Dr. Alessandro Piga founded Techwald Holding SPA. He occupies the position of Chairman and CEO at ElectroPhysiology Frontiers SpA and Managing Director at Techwald Holding SPA. He is also on the board of SoniVie Ltd., Life Care Capital SpA, EP Solutions SA, and Beyeonics Surgical Ltd. He received a graduate degree from the University of Turin.

Giovanni Camussi MD is Professor Emeritus within the Department of Medical Sciences, University of Torino, Italy. He has previously been a Research Associate Professor in Microbiology and Pathology at the University at Buffalo, State University of New York, USA, and subsequently was a Full Professor of Nephrology at the University of Naples, at the University of Pavia, and at University of Torino (Italy), and an Adjunct Professor of Medicine, Department of Medicine of Brown University, Providence (RI), USA. He has been President of School of Medical Biotechnology, Director of the Department of Internal Medicine, and Director of the Laboratory of Renal and Vascular Pathophysiology at the University of Torino. He is currently the Scientific Coordinator of stem cell research projects of 2i3T incubator within the Molecular Biotechnology Center at the University of Torino and the Chief of Scientific Advisory Board EvoBiotech s.r.l. Since 2006 he has focused his research activities on characterization of human stem/progenitor cell derived extracellular vesicles (exosomes / microvesicles), showing that they may carry nucleic acids in a protective way. He was co-chair (2016) and chair (2018) for the Gordon Conferences on Extracellular Vesicles. Recently, with EvoBiotech, he developed a platform for engineering plant-derived extracellular vesicles as carriers of ribonucleic acid for drug delivery. He has over 600 publications listed in PubMed-indexed journals.